Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating safety, tolerability, pharmacokinetics, and antitumor activity of Cisplatin Micelle Injection (HA132) in patients with advanced malignant sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Solid Tumors

Drugs mentioned

• Cisplatin Micelle Injection (HA132) (cisplatin micelle formulation (HA132))

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Advanced Malignant Solid Tumors | Phase 1, Phase 2 | Status: UNKNOWN